C. Abletshauser

Reduction of Platelet Activity Markers in Type II Hypercholesterolemic Patients by a HMG-CoA-Reductase Inhibitor

G. Huhle, C. Abletshauser, Nóra Mayer et al. · Thrombosis Research · 1999 · 124 citations

Medicine, Hematology, Pharmacology +15

Fluvastatin Slow-Release Lowers Platelet-Activating Factor Acetyl Hydrolase Activity: A Placebo-Controlled Trial in Patients with Type 2 Diabetes

Karl Winkler, C. Abletshauser, I. Friedrich et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 78 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

A randomized, double‐blind study of certoparin vs. unfractionated heparin to prevent venous thromboembolic events in acutely ill, non‐surgical patients: CERTIFY Study

Hanno Riess, Sylvia Haas, Ulrich Tebbe et al. · Journal of Thrombosis and Haemostasis · 2010 · 58 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Dysregulation of coronary microvascular reactivity in asymptomatic patients with type 2 diabetes mellitus

Mitsuru Momose, C. Abletshauser, Jodi Neverve et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2002 · 57 citations

Medicine, Cardiology, Internal Medicine +16

Effects of fluvastatin therapy on lipids, antioxidants, oxidation of low density lipoproteins and trace metals

W. Leonhardt, T. Kurktschiev, Peter Lattke et al. · European Journal of Clinical Pharmacology · 1997 · 56 citations

Life Sciences, Biochemistry, Pharmacology +14